Heart Disease Clinical Trials in Dallas

Showing 21-40 of 384 trials

CLEANer Aspiration for Pulmonary Embolism

NCT06189313

To evaluate the safety and efficacy of the Cleaner™ Pro Thrombectomy System for aspiration thrombectomy in patients with acute pulmonary embolism (PE).

Pulmonary EmbolismAcute Pulmonary EmbolismCardiovascular Diseases+1 more

Argon Medical Devices125 participantsStarted Jan 2025

Aurora, Colorado, United States • Washington D.C., District of Columbia, United States • Pensacola, Florida, United States +11 more locations

RECRUITINGPhase 3< 1 mile

A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation

NCT06200207

The study is being done to see if ziltivekimab can be used to treat participants living with heart failure and inflammation. Participants will either get ziltivekimab (active medicine) or placebo (inactive substance that looks like the study medicine but does not contain any medicine). The treatment participants get is decided by chance. Participant's chance of getting ziltivekimab or placebo is the same. Ziltivekimab is not yet approved in any country or region in the world. It is a new medicine that doctors cannot prescribe. The study is expected to last for up to 1 year and 4 months.

Heart FailureSystemic Inflammation

Novo Nordisk A/S680 participantsStarted Apr 2024

Alexander City, Alabama, United States • Fairhope, Alabama, United States • Little Rock, Arkansas, United States +236 more locations

CLEANer Aspiration for Pulmonary Embolism

A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation

Heart Disease Trials in Other Cities

IEEM-Heat and Heart Failure

The SEEA (SCI Energy Expenditure and Activity) Study

Efficacy of LoDoCo in Improving Exercise Capacity Among Patients With HFpEF and Inflammation

NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study

Shockwave C2+ 2Hz Coronary IVL Catheter in Calcified Coronary Arteries (Disrupt CAD DUO)

A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

Product Surveillance Registry

Digital Remote Home Monitoring for Heart Failure

A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia

Sternal Block With Liposomal Bupivacaine vs. Saline Prior to Incision in Cardiac Surgery

A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma

Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD

Lumason® Infusion vs. Bolus Administrations

EXCOR Active Driving System for the EXCOR Pediatric VAD IDE Study

A Phase IIb Study of AZD5462 in Patients With Chronic Heart Failure

Conduction System Pacing International Registry (CONSPIRE)

Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment

Other Conditions in Dallas